Healthy Lifestyle Can Overcome Genetic Predisposition to Premature Death
By Lori Solomon HealthDay Reporter
WEDNESDAY, May 1, 2024 -- Adherence to healthy lifestyles can largely overcome the genetic risk for a shorter lifespan, according to a study published online April 29 in BMJ Evidence Based Medicine.
Zilong Bian, from the Zhejiang University School of Medicine in Hangzhou, China, and colleagues investigated associations of genetic and lifestyle factors with lifespan using data from 353,742 adult participants in the U.K. Biobank. Participants were categorized by lifespan categories, polygenetic risk score, and lifestyle score.
The researchers found that the risk for death for individuals with a genetic predisposition to a short lifespan was higher versus those with a genetic predisposition to a long lifespan (hazard ratio, 1.21). Unfavorable lifestyle classification was also tied to a higher risk for death (hazard ratio, 1.78) than that seen in the favorable lifestyle category. The combination of a genetic predisposition to a short lifespan and an unfavorable lifestyle raised death rates 2.04-fold compared with that seen in individuals with a genetic predisposition to a long lifespan and a favorable lifestyle. The combined lifestyle factors of never smoking, regular physical activity, adequate sleep duration, and a healthy diet decreased the risk for death before age 75 years.
"Public health policies for improving healthy lifestyles would serve as potent complements to conventional health care and mitigate the influence of genetic factors on human lifespan," the authors write.
One author disclosed financial ties to BioAge Labs.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...
DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD
WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...
Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease
TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.